Colgate-Palmolive Company vs iShares MSCI China ETF — how do they compare? Colgate-Palmolive Company trades at $90.95 (market cap $72.84B), while iShares MSCI China ETF trades at $53.65. The key difference: Colgate-Palmolive Company pays a 2.33% dividend while iShares MSCI China ETF pays none, and Colgate-Palmolive Company is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.
| CL | MCHI | |
|---|---|---|
Market Cap | $72.84B | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $99.14 | $66.99 |
52-Week Low | $74.98 | $50.48 |
Enterprise Value | $79.48B | — |
Dividend Yield | 2.33% | — |
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.21, up 1.05% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 60.06% gross margins and 822.05% ROE, though valuation metrics appear elevated with a P/E of 36.13. Recent dividend declarations and positive analyst coverage (42% buy rating) support the defensive stock's appeal amid market rotation into stable cash flow names.
Outlook remains positive with a $97 consensus price target representing 4% upside, though premium valuation and North American segment softness present headwinds. The company's 64-year dividend growth streak and global diversification provide stability, while inflation pressures and competitive threats require monitoring for sustained outperformance.
MCHI trades at $52.53, down 1.13% on the day, with neutral technical signals from both moving averages and oscillators. The ETF shows mixed sentiment amid China's factory rebound driven by AI hardware exports and Beijing's $295 billion AI infrastructure plan. Recent news highlights China's tech sector momentum but also persistent geopolitical tensions with US restrictions on Chinese tech firms.
Outlook remains balanced with AI-driven growth potential offset by value trap risks and regulatory uncertainties. The ETF faces headwinds from US-China tech rivalry but benefits from China's massive domestic AI investment program. Investors should weigh sector-specific opportunities against broader macroeconomic and geopolitical challenges.
Trailing returns across standard periods
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →